Skip to main content
Browse topics  Search all clinical trials

Clinical trials : ophthalmology

Showing 1 -5 of 5 results
Glaucoma is the second leading cause of blindness in the world, and primary open angle glaucoma (POAG) is the most common of all types. It is characterized by a progressive loss of retinal ganglion cells (RGC) and their axons leading to visible changes in optic nerve head (ONH) and to deficits of visual function...

Manhattan Eye, Ear, and Throat Hospital | 210 East 64th Street | New York | NY 10065
Glaucoma is a form of progressive degeneration of optic nerve and is the second leading cause of irreversible blindness in the United States. Because disc hemorrhage is associated with glaucoma progression, knowledge of detailed longitudinal changes in retinal layers and visual field and of the associations between those changes will be helpful in managing glaucoma patients and preventing blindness from glaucoma...

Manhattan Eye, Ear, and Throat Hospital | 210 East 64th Street | New York | NY 10065
This multi-center, randomized trial aims to determine whether long term use of the antiviral valacyclovir can suppress or reduce complications of Herpes Zoster Ophthalmicus (HZO) including new or worsening dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis and/or postherpetic neuralgia compared with placebo.

Comparing ultrastructural characteristics of aqueous humor samples taken from glaucoma patients undergoing cataract surgery with normal controls.

Manhattan Eye, Ear, and Throat Hospital | 210 East 64th Street | New York | NY 10065